Tunable LED Lamp Spectral Control for Circadian Rhythm

Resolve Bottlenecks,
Find Innovative Solutions
Generate Solutions

Solution Overview

Problem

Conventional light sources, such as incandescent and fluorescent bulbs, disrupt sleep patterns and circadian rhythms due to their blue light emission, leading to melatonin suppression and associated health issues like sleep disorders, hypertension, heart disease, and cancer, while attempts to filter out blue light compromise color rendering properties.

Innovation Solution

A tunable LED lamp with a drive circuit and output-select controller that adjusts the spectral output of red, blue, cyan, and mint LED dies to minimize melatonin suppression in pre-sleep configurations, enhance blue light for phase-shifting, and maintain optimal color rendering indices in general lighting scenarios, using specific current ratios and color filters to achieve biologically adjusted light.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Illumination intensity

If blue light emission is used in conventional light sources, then illumination intensity and energy efficiency are improved, but melatonin suppression and disruption of circadian rhythms occur

Engineering Contradiction:
Improveillumination intensityVSAvoidmelatonin suppression
Core Design Contradiction:
Illumination intensityVSObject-affected harmful factors

Solution Approach 1:

The patent segments the blue light spectrum into multiple discrete wavelength components (440nm, 460nm, 480nm) and independently controls each using separate LED chips with individual drive circuits. This allows selective suppression of melatonin-suppressing wavelengths while maintaining illumination from non-suppressing wavelengths, resolving the contradiction between illumination intensity and melatonin suppression.

Inventive Principle:
Principle #1Segmentation

Solution Approach 2:

The patent dynamically changes the spectral parameters by adjusting the intensity ratios of different wavelength components through programmable drive circuits. By modifying the relative intensities of 440nm, 460nm, 480nm, and other wavelength LEDs, the system can switch between full-spectrum mode (high illumination) and melatonin-suppression mode (reduced harmful wavelengths), resolving the contradiction adaptively.

Inventive Principle:
Principle #35Parameter changes

2Object-affected harmful factors

If blue light is filtered out to reduce melatonin suppression, then health impacts are reduced, but color rendering properties deteriorate

Engineering Contradiction:
Improvemelatonin suppressionVSAvoidcolor rendering properties
Core Design Contradiction:
Object-affected harmful factorsVSManufacturing precision

Solution Approach 1:

Instead of filtering out all blue light, the patent segments the blue spectrum into specific wavelength components (440nm, 460nm, 480nm) and selectively controls each. This allows suppression of harmful wavelengths (e.g., 460nm peak melatonin suppression) while preserving beneficial blue wavelengths for color rendering, thus resolving the contradiction between health safety and color quality.

Inventive Principle:
Principle #1Segmentation

Solution Approach 2:

The patent uses a composite approach combining multiple LED chip types with different spectral characteristics (440nm, 460nm, 480nm blue LEDs plus cyan, green, yellow, red LEDs) to create a multi-component light source. This composite spectrum maintains color rendering accuracy by preserving essential wavelength components while suppressing harmful ones, resolving the contradiction between health safety and color rendering.

Inventive Principle:
Principle #40Composite materials

3Adaptability or versatility

If multiple LED dies with different wavelengths are used to adjust spectral output, then adaptability to biological circumstances is improved, but device complexity increases

Engineering Contradiction:
Improvespectral output adjustabilityVSAvoiddevice complexity
Core Design Contradiction:
Adaptability or versatilityVSDevice complexity

Solution Approach 1:

The patent segments the light source into modular LED chip groups (440nm, 460nm, 480nm blue chips plus cyan, green, yellow, red chips), each with dedicated drive circuitry. This modular segmentation enables independent control of spectral components for biological adaptability while keeping each module relatively simple and manageable, resolving the contradiction between versatility and complexity.

Inventive Principle:
Principle #1Segmentation

Solution Approach 2:

The patent implements a universal control system that can generate multiple pre-programmed spectral configurations (morning light, afternoon light, evening light, sleep mode) from the same hardware platform. The output-select controller and drive circuits serve multiple functions by switching between different wavelength intensity combinations, reducing overall device complexity while maintaining high adaptability to different biological circumstances.

Inventive Principle:
Principle #6Universality (Multi-functionality)

Applied Scientific Principles

This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.

Function Achieved in This Case

The LED lamp effectively reduces melatonin suppression in pre-sleep configurations, enhances circadian rhythm phase-shifting, and maintains high visual quality and color rendering indices across all settings, addressing the health impacts of conventional light sources without compromising light quality.

Implementation Method 1

a plurality of LED dies mounted on a support coupled to the housing, wherein each of the plurality of LED dies is electrically coupled to and driven by the drive circuit

Methodology Applied
Scientific EffectLight-emitting diode (LED): Light Emitting Diode

Implementation Method 2

using specific current ratios and color filters to achieve biologically adjusted light

Methodology Applied
Scientific EffectOptical filtering: Filter (optical)

Data Source

PatentEP2788674B1Tunable LED lamp for producing biologically-adjusted light
Publication Date: 2016.08.31 BIOLOGICAL ILLUMINATION LLC
  • EP2788674B1 patent drawingFigure 1
  • EP2788674B1 patent drawingFigure 2
  • EP2788674B1 patent drawingFigure 3

AI summary

A tunable light-emitting diode (LED) lamp (100) for producing an adjustable light output is provided. In one embodiment, the LED lamp (100) may include a drive circuit (440) for driving LED dies in one of a plurality of light output configurations (e.g., a pre-sleep configuration, a phase-shift configuration, and a general lighting configuration). Further, the LED lamp (100) may include an output-select controller (445) and/or input sensor electrically coupled to the drive circuit to select the light output configuration. As such, the LED lamp (100) is tunable to generate different levels of spectral output, appropriate for varying biological circumstance, while maintaining a commercially acceptable light quality and color rendering index.